CD137 antibody (Ectodomain)
TNFRSF9
Reactivity: Human
FACS, IF
Host: Mouse
Monoclonal
0-N-185
unconjugated
-
-
Target
See all CD137 (TNFRSF9) Antibodies
-
CD137 (TNFRSF9)
(Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9))
-
Binding Specificity
-
Ectodomain
-
Reactivity
-
Human
-
Host
-
Mouse
-
Clonality
-
Monoclonal
-
Conjugate
-
This CD137 antibody is un-conjugated
-
Application
-
Flow Cytometry (FACS), Immunofluorescence (IF)
-
Cross-Reactivity
-
Human
-
Cross-Reactivity (Details)
-
Calculated cross reactivity: Hu
-
Characteristics
-
CD137 (4-1BB, TNFRSF9, 4-1BB ligand receptor, CD137, CD137 antigen, CDw137, ILA, MGC2172, T-cell antigen 4-1BB homolog, T-cell antigen ILA, Tumor necrosis factor receptor superfamily member 9 precursor) (BSA & Azide Free)
-
Purification
-
Purified by Protein G affinity chromatography.
-
Immunogen
-
Ectodomain of human 4-1BB recombinant protein (30kD). Cellular Localization: Cell membrane. Epitope: Ectodomain.
-
Clone
-
0-N-185
-
Isotype
-
IgG1 kappa
-
Top Product
-
Discover our top product TNFRSF9 Primary Antibody
-
-
-
Application Notes
-
Optimal working conditions should be determined by the investigator.
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Buffer
-
Supplied as a liquid in PBS, pH 7.4.
-
Storage
-
4 °C,-20 °C
-
Storage Comment
-
4°C (-20°C Glycerol)
-
-
Target
-
CD137 (TNFRSF9)
(Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9))
-
Alternative Name
-
CD137 (TNFRSF9 Products)
-
Synonyms
-
TNFRSF9 antibody, zgc:136557 antibody, 4-1BB antibody, CD137 antibody, CDw137 antibody, ILA antibody, A930040I11Rik antibody, AA408498 antibody, AI325004 antibody, Cd137 antibody, Ly63 antibody, tumor necrosis factor receptor superfamily member 9 antibody, TNF receptor superfamily member 9 antibody, tumor necrosis factor receptor superfamily, member 9a antibody, tumor necrosis factor receptor superfamily, member 9 antibody, TNFRSF9 antibody, tnfrsf9a antibody, Tnfrsf9 antibody
-
Background
-
Cellular Localization: Cell membrane. Epitope: Ectodomain.
-
Pathways
-
Cancer Immune Checkpoints
-